Recursion to Participate in Upcoming Investor Conferences
May 01, 2024 08:01 ET
|
Recursion Pharmaceuticals
SALT LAKE CITY, May 01, 2024 (GLOBE NEWSWIRE) -- Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to industrialize drug discovery, today announced its...
Recursion to Participate in Upcoming Investor Conference
April 02, 2024 08:00 ET
|
Recursion Pharmaceuticals
SALT LAKE CITY, April 02, 2024 (GLOBE NEWSWIRE) -- Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to industrialize drug discovery, today announced its...
Evaxion Hosts R&D Day and Unveils the Broad Potential of Its AI-Immunology™ Platform
March 19, 2024 07:30 ET
|
Evaxion Biotech
The proprietary AI-Immunology™ platform brings the potential for a new era in vaccine discovery, design and development using advanced AI and machine learning technologiesAI-Immunology™ outcompetes...
Recursion to Participate in Upcoming Investor Conferences
March 01, 2024 07:59 ET
|
Recursion Pharmaceuticals
SALT LAKE CITY, March 01, 2024 (GLOBE NEWSWIRE) -- Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to industrialize drug discovery, today announced its...
IMU Biosciences secures £11.5 million in Series A funding to revolutionise immune powered precision medicine
January 24, 2024 03:00 ET
|
IMU Biosciences
Board strengthened with appointments of Tim Haines (Abingworth) as Non-executive Chair and Dr Oliver Nussbaumer (co-founder of GammaDelta Therapeutics and Adaptate Biotherapeutics) and Dr Inga Deakin...
Leading TechBio Investment Firm ARTIS Ventures Announces 2023 Class of Healthcare and Life Sciences Fellows
January 12, 2024 12:00 ET
|
ARTIS Ventures
San Francisco, CA, Jan. 12, 2024 (GLOBE NEWSWIRE) -- ARTIS Ventures, a leading venture firm pioneering investments in the TechBio space, today announced its newest class of AV Fellows. Selected from...
Recursion Celebrates Opening of Its Canadian Headquarters in Toronto with Government Officials and the Biotech Ecosystem
June 26, 2023 11:48 ET
|
Recursion Pharmaceuticals
TORONTO, June 26, 2023 (GLOBE NEWSWIRE) -- Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to industrialize drug discovery, today celebrated the opening of its...
With the Potential to Revolutionize Personalized Health, Range Biotechnologies Receives $5.2 Million in Seed Funding Led by TechBio-Focused ARTIS Ventures
June 12, 2023 11:00 ET
|
ARTIS Ventures
San Francisco, CA, June 12, 2023 (GLOBE NEWSWIRE) -- Range Biotechnologies (“Range Bio”), a proteomics-focused biotech company that has developed an innovative translational platform to enable...
Atavistik Bio Announces Publication in Science by Co-Founder Jared Rutter Describing Foundational Technology for its Atavistik Metabolite-Protein Screening (AMPS) Platform
March 13, 2023 08:00 ET
|
Atavistik Bio, Inc.
MIDAS (mass spectrometry integrated with equilibrium dialysis for the discovery of allostery systematically), in-licensed and industrialized by Atavistik Bio as the basis of AMPS, is the first...
Leading TechBio Investment Firm ARTIS Ventures Announces 2022 Class of Healthcare and Life Sciences Fellows
December 14, 2022 11:00 ET
|
ARTIS Ventures
San Francisco , Dec. 14, 2022 (GLOBE NEWSWIRE) -- ARTIS Ventures, a leading venture firm pioneering investments in the TechBio space, today announced its newest class of AV Fellows. The 2022 fellows...